Alpha-fetoprotein as a prognostic factor in alpha-fetoprotein-negative hepatocellular carcinoma - integration into post-resection prognostic nomograms.

IF 2.9 Q2 ONCOLOGY
Wspolczesna Onkologia-Contemporary Oncology Pub Date : 2025-01-01 Epub Date: 2025-04-09 DOI:10.5114/wo.2025.149087
Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Naoki Yamanaka
{"title":"Alpha-fetoprotein as a prognostic factor in alpha-fetoprotein-negative hepatocellular carcinoma - integration into post-resection prognostic nomograms.","authors":"Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Naoki Yamanaka","doi":"10.5114/wo.2025.149087","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to validate the prognostic value of alpha- fetoprotein (AFP) in AFP-negative hepatocellular carcinoma (HCC) and develop an AFP-integrated nomogram for post-resection recurrence-free survival (RFS) and overall survival (OS).</p><p><strong>Material and methods: </strong>This retrospective study analyzed 453 HCC patients with preoperative AFP ≤ 20 ng/ml who underwent curative resection, divided into training (<i>n</i> = 317) and validation (<i>n</i> = 136) cohorts. The optimal AFP cutoff was determined using maximized χ<sup>2</sup> values. Nomograms were developed with repeated least absolute shrinkage and selection operator variable selection and stepwise Cox regression. Model performance was assessed using concordance (C-) indices, time-dependent area under the receiver operating characteristic curves (AUCs), calibration plots, and Kaplan-Meier (KM) curves.</p><p><strong>Results: </strong>An alpha-fetoprotein cutoff of 7 ng/ml stratified patients for both RFS and OS (<i>p</i> < 0.001). The recurrence-free survival nomogram included AFP, age, sex, multiple tumors, and cirrhosis, while the OS nomogram incorporated AFP, albumin-bilirubin score, the up-to-7 criterion, des-γ-carboxy prothrombin, vascular invasion, and histological grade. In the training cohort, the nomograms demonstrated C-indices of 0.64 (95% CI: 0.60-0.68) for RFS and 0.72 (0.67-0.76) for OS. Validation cohort C-indices were 0.64 (0.62-0.65) for RFS and 0.67 (0.65-0.68) for OS. Time-dependent AUCs and calibration plots confirmed the predictive accuracy of the nomograms, and KM curves showed clear separation between high- and low-risk groups, further highlighting their clinical utility.</p><p><strong>Conclusions: </strong>Alpha-fetoprotein retains prognostic value even within the clinically normal range for HCC. The AFP-integrated post-resection nomograms demonstrated acceptable predictive performance for AFP-negative patients, potentially enhancing personalized management strategies.</p>","PeriodicalId":49354,"journal":{"name":"Wspolczesna Onkologia-Contemporary Oncology","volume":"29 1","pages":"69-76"},"PeriodicalIF":2.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051881/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wspolczesna Onkologia-Contemporary Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/wo.2025.149087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study aimed to validate the prognostic value of alpha- fetoprotein (AFP) in AFP-negative hepatocellular carcinoma (HCC) and develop an AFP-integrated nomogram for post-resection recurrence-free survival (RFS) and overall survival (OS).

Material and methods: This retrospective study analyzed 453 HCC patients with preoperative AFP ≤ 20 ng/ml who underwent curative resection, divided into training (n = 317) and validation (n = 136) cohorts. The optimal AFP cutoff was determined using maximized χ2 values. Nomograms were developed with repeated least absolute shrinkage and selection operator variable selection and stepwise Cox regression. Model performance was assessed using concordance (C-) indices, time-dependent area under the receiver operating characteristic curves (AUCs), calibration plots, and Kaplan-Meier (KM) curves.

Results: An alpha-fetoprotein cutoff of 7 ng/ml stratified patients for both RFS and OS (p < 0.001). The recurrence-free survival nomogram included AFP, age, sex, multiple tumors, and cirrhosis, while the OS nomogram incorporated AFP, albumin-bilirubin score, the up-to-7 criterion, des-γ-carboxy prothrombin, vascular invasion, and histological grade. In the training cohort, the nomograms demonstrated C-indices of 0.64 (95% CI: 0.60-0.68) for RFS and 0.72 (0.67-0.76) for OS. Validation cohort C-indices were 0.64 (0.62-0.65) for RFS and 0.67 (0.65-0.68) for OS. Time-dependent AUCs and calibration plots confirmed the predictive accuracy of the nomograms, and KM curves showed clear separation between high- and low-risk groups, further highlighting their clinical utility.

Conclusions: Alpha-fetoprotein retains prognostic value even within the clinically normal range for HCC. The AFP-integrated post-resection nomograms demonstrated acceptable predictive performance for AFP-negative patients, potentially enhancing personalized management strategies.

甲胎蛋白作为甲胎蛋白阴性肝细胞癌的预后因素-纳入术后预后x线图。
简介:本研究旨在验证甲胎蛋白(AFP)在AFP阴性肝细胞癌(HCC)中的预后价值,并开发一种用于术后无复发生存期(RFS)和总生存期(OS)的AFP综合nomogram。材料和方法:本回顾性研究分析了453例术前AFP≤20 ng/ml行根治性切除的HCC患者,分为训练组(n = 317)和验证组(n = 136)。采用最大χ2值确定AFP的最佳截止点。通过重复最小绝对收缩和选择算子变量选择和逐步Cox回归来开发nomogram。采用一致性(C-)指数、受试者工作特征曲线(auc)下的时变面积、校准图和Kaplan-Meier (KM)曲线来评估模型的性能。结果:RFS和OS分层患者的甲胎蛋白均为7 ng/ml (p < 0.001)。无复发生存图包括AFP、年龄、性别、多发肿瘤、肝硬化,OS包括AFP、白蛋白-胆红素评分、达-7标准、des-γ-羧基凝血酶原、血管侵犯、组织学分级。在训练队列中,模态图显示RFS的c指数为0.64 (95% CI: 0.60-0.68), OS的c指数为0.72(0.67-0.76)。验证队列c指数RFS为0.64 (0.62-0.65),OS为0.67(0.65-0.68)。随时间变化的auc和校准图证实了nomographic的预测准确性,KM曲线显示出高风险组和低风险组之间的明显分离,进一步突出了它们的临床实用性。结论:甲胎蛋白在HCC的临床正常范围内仍具有预后价值。对于afp阴性的患者,afp综合术后x线图显示出可接受的预测性能,潜在地增强了个性化的管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
22
审稿时长
4-8 weeks
期刊介绍: Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists, radiologists, pathologists, radiotherapists, palliative care specialists, psychologists, nutritionists, and representatives of any other professions, whose interests are related to cancer. Manuscripts devoted to basic research in the field of oncology are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信